author-photo

Catherine Dive-Pouletty

Genzyme

15

Papers

134

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

2017 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (27)
Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis.

2016 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (28)
Assessing Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing MS: Use of “Number Needed to Treat” Analysis (P3.245)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (2)
Teriflunomide Shows Consistent Clinical Efficacy On Severe Relapses Across temso and tower: 2 Phase 3 trials

2015 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Teriflunomide Shows Consistent Clinical Efficacy on Severe Relapses across Two Phase 3 Trials in Patients with Relapsing forms of Multiple Sclerosis, TEMSO and TOWER (P7.212)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
How Satisfied with Their Treatment Are Patients with MS? Psychometric Evaluation of the Treatment Satisfaction Questionnaire for Medication (TSQM) (P3.236)

2015 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study

2014 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (20)
Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis.

2014 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.

2013 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (31)
Impact of Relapses with Sequelae on Disability, Health-Related Quality of Life, and Fatigue in a Population with Relapsing Forms of Multiple Sclerosis Using Data from TEMSO, a Pivotal Phase III Teriflunomide Trial (P07.082)

2012 Neurology
Show All
- Source
- Cite
- Save
Citations (2)